SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
높은 성장
회사의 매출은 지난 3년간 꾸준히 성장해왔으며, 연평균 84.95%의 증가율을 기록했습니다.
성장 중
회사는 성장 단계에 있으며, 최신 연간 수익은 미화 2.89M에 달합니다.
과소 평가된
회사의 최신 PE은 -0.79로, 최근 3년 기준 낮은 백분위 범위에 속합니다.
기관 매수
최신 기관 보유 주식 수는 459.74K주이며, 전 분기 대비 14.17% 증가했습니다.
더 뱅가드가 보유
스타 투자자 더 뱅가드이(가) 이 주식 44.44K주를 보유하고 있습니다.